These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22045955)

  • 1. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole.
    Kim MM; Vikram HR; Kusne S; Seville MT; Blair JE
    Clin Infect Dis; 2011 Dec; 53(11):1060-6. PubMed ID: 22045955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
    Levy ER; McCarty JM; Shane AL; Weintrub PS
    Clin Infect Dis; 2013 Jun; 56(11):1573-8. PubMed ID: 23463636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole therapy for chronic refractory coccidioidomycosis.
    Stevens DA; Rendon A; Gaona-Flores V; Catanzaro A; Anstead GM; Pedicone L; Graybill JR
    Chest; 2007 Sep; 132(3):952-8. PubMed ID: 17573510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
    J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory coccidioidomycosis treated with posaconazole.
    Anstead GM; Corcoran G; Lewis J; Berg D; Graybill JR
    Clin Infect Dis; 2005 Jun; 40(12):1770-6. PubMed ID: 15909265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
    Catanzaro A; Cloud GA; Stevens DA; Levine BE; Williams PL; Johnson RH; Rendon A; Mirels LF; Lutz JE; Holloway M; Galgiani JN
    Clin Infect Dis; 2007 Sep; 45(5):562-8. PubMed ID: 17682989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
    Thompson GR; Bays D; Cohen SH; Pappagianis D
    Antimicrob Agents Chemother; 2012 Jan; 56(1):563-4. PubMed ID: 22005993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
    Heinz WJ; Egerer G; Lellek H; Boehme A; Greiner J
    Mycoses; 2013 May; 56(3):304-10. PubMed ID: 23170837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of coccidioidal meningitis with voriconazole.
    Cortez KJ; Walsh TJ; Bennett JE
    Clin Infect Dis; 2003 Jun; 36(12):1619-22. PubMed ID: 12802765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole for chronic refractory coccidioidal meningitis.
    Schein R; Homans J; Larsen RA; Neely M
    Clin Infect Dis; 2011 Dec; 53(12):1252-4. PubMed ID: 21987729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
    Queiroz-Telles F; Goldani LZ; Schlamm HT; Goodrich JM; Espinel-Ingroff A; Shikanai-Yasuda MA
    Clin Infect Dis; 2007 Dec; 45(11):1462-9. PubMed ID: 17990229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
    Al-Badriyeh D; Slavin M; Liew D; Thursky K; Downey M; Grigg A; Bajel A; Stewart K; Kong DC
    J Antimicrob Chemother; 2010 May; 65(5):1052-61. PubMed ID: 20237074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage treatment of histoplasmosis with posaconazole.
    Restrepo A; Tobón A; Clark B; Graham DR; Corcoran G; Bradsher RW; Goldman M; Pankey G; Moore T; Negroni R; Graybill JR
    J Infect; 2007 Apr; 54(4):319-27. PubMed ID: 16824608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
    Gamaletsou MN; Sipsas NV; Kontoyiannis DP; Tsiakalos A; Kontos AN; Stefanou I; Kordossis T
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):409-11. PubMed ID: 22975207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
    Walsh TJ; Raad I; Patterson TF; Chandrasekar P; Donowitz GR; Graybill R; Greene RE; Hachem R; Hadley S; Herbrecht R; Langston A; Louie A; Ribaud P; Segal BH; Stevens DA; van Burik JA; White CS; Corcoran G; Gogate J; Krishna G; Pedicone L; Hardalo C; Perfect JR
    Clin Infect Dis; 2007 Jan; 44(1):2-12. PubMed ID: 17143808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole: an oral triazole with an extended spectrum of activity.
    Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
    Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D; Buadi FK; McClune B
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.